CROX: GAAP Loss. Record Gross Profit. Growing EPS. Technical Setup.
Highest gross profit in history, impairment-driven GAAP loss, wholesale divergence across geographies, stock hit hard on guidance. Here's how the technicals can shed light on your next move.
Key Takeaways (TL;DR)
GAAP headline loss misleading: Reported Q2 2025 net loss of $492M (−$8.82/share) driven by $737M in non-cash impairments.
Core business solid: Adjusted operating income of $309M (26.9% margin) vs. 29.3% last year; adjusted EPS up 5.5% YoY to $4.23.
Market reaction brutal: Stock plunged ~29% in one session, slicing through all major moving averages and key Fib retracements.
Oversold extremes: Multi-timeframe RSI readings collapsed to rare lows. Hourly RSI hit ~11.
Critical support: $70.90–69.31 is the make-or-break zone; failure opens risk to $63–55.
Resistance fortress: Heavy EMA and Fib cluster between $90–105 is the key barrier for trend reversal.
Full trade plan below
Earnings Overview
Crocs delivered Q2 2025 results that looked ugly on a GAAP basis but strong under the hood. While the company reported a GAAP net loss of $492M (−$8.82/share), this was almost entirely driven by non-cash impairments of $430M tied to the indefinite-lived HEYDUDE trademark and $307M tied to HEYDUDE goodwill. These impairments ran through SG&A, pushing reported SG&A to nearly 99% of revenues vs. 32% last year.
Stripping out these charges, adjusted operating income was $309M with a 26.9% margin—only slightly lower than last year’s 29.3% and a clear sign that core profitability remains intact. Adjusted EPS came in at $4.23, up 5.5% YoY.
Top-Line Performance
Consolidated revenue grew 3.4% YoY to $1.15B, with mixed channel and geographic trends:
Crocs Brand: +5% revenue growth to $960M, with international up 18.1% offsetting North America down 6.5%.
International wholesale surged +14.1%, and DTC was even stronger at +24.6%.
North America wholesale fell −4.3% and DTC dropped −7.7%, showing softness in the domestic market.
HEYDUDE Brand: −3.9% to $190M, with wholesale down −12.4% but DTC up 7.6%.
The key story: wholesale strength is coming from outside North America, while U.S. wholesale is in retreat. A shift that could reshape Crocs’ growth mix going forward.
Margins & Profitability
Gross margin improved 30 bps to 61.7%—a record high for the company.
Adjusted SG&A was $399M (34.7% of revenue) vs. $356M (32.0%) last year—reflecting higher investment and inflationary pressures, but still within healthy operating parameters.
Adjusted operating margin: 26.9% (vs. 29.3% last year).
The impairment charges explain the sharp contrast between GAAP and non-GAAP performance: operationally, CROX is still generating significant profit dollars.
Cash Flow & Balance Sheet Strength
Cash flow is where the quarter shines:
Free cash flow: $269M for Q2, $187M YTD (funding debt reduction and buybacks).
Cash on hand: $201M, up from $168M last year.
Debt: reduced by $105M in the quarter to $1.38B.
Share repurchases: $133M (1.3M shares at ~$102 average).
This capital return policy is notable. CROX is repurchasing stock aggressively while still paying down debt.
Stock Reaction: Why CROX 0.00%↑ Collapsed 29% in One Day
Despite the solid adjusted results, Crocs shares were hammered, plunging nearly 30% on August 7 to close at $74.39, erasing roughly a quarter of its market cap in a single session.
The selloff was triggered by surprisingly weak Q3 guidance:
Management expects revenue to fall 9–11% YoY, citing soft U.S. consumer demand for non-essential goods.
CEO Andrew Rees warned of a $40M hit from newly imposed U.S. import tariffs in the second half of 2025.
Tariff-related price hikes could further pressure volumes.
Rees also noted that consumer attention in the U.S. may shift toward classic sports footwear in the lead-up to the 2026 World Cup and 2028 Olympics, potentially a competitive headwind for the Crocs brand.
The combination of near-term demand concerns, macro uncertainty, and tariff impacts outweighed the positive cash flow story in investors’ minds, prompting a violent repricing.
Management Commentary
CEO Andrew Rees acknowledged the strong Q2 performance but stressed caution given the challenging operating environment. CROX 0.00%↑ is taking proactive steps:
Implemented $50M in cost savings.
Reduced inventory receipts to manage supply/demand balance.
Pulling back on promotions to protect brand equity.
These measures will likely weigh on near-term revenue but are intended to protect margins and cash flow. A disciplined, long-term approach.
For Q3 2025, CROX guides to:
Revenue down 9–11% YoY.
Adjusted operating margin: 18–19%, including a ~170 bps hit from tariffs.
While guidance signals a slowdown, it also reflects a deliberate margin-protection strategy rather than a collapse in demand fundamentals.
Multi-Timeframe Technical Analysis
Multi-timeframe technicals show a battle between short-term mean reversion and medium-term caution. Great opportunities in short-and medium-term with risk-managed trade plan below!
A) Weekly Timeframe
Post-earnings, CROX 0.00%↑ weekly chart suffered one of its most aggressive breakdowns in years. A prior bullish impulse wave from late 2023 topped in Q1 2025, followed by a sharp ABC correction. That C-wave accelerated violently after Q2 results, slicing through the EMA20, EMA50, EMA100, and EMA200 in a single gap-down candle.
Elliott structure now shows price potentially completing its corrective wave C near the $74–75 area. This level sits just above key Fib extensions from the $122.84 swing high:
1.272 ext: $76.12
1.414 ext: $70.90
1.618 ext: $63.41 (worst-case zone if support fails)
Weekly RSI has collapsed to ~30, while MACD momentum remains negative. A reversal attempt here would require reclaiming the $90–105 zone, where multiple retracement and EMA resistances converge.
